Stem Cell Therapy Targets: Repêchage!

[1]  Deepak L. Bhatt,et al.  2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2021, Circulation.

[2]  E. Marbán.  A phoenix rises from the ashes of cardiac cell therapy , 2021, Nature Reviews Cardiology.

[3]  T. Henry,et al.  Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair—A Systematic Review , 2021, Cells.

[4]  M. Budoff,et al.  Rationale and Design of the Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR) Trial. , 2021, American heart journal.

[5]  B. Tamarappoo,et al.  Left atrial stiffness in women with ischemia and no obstructive coronary artery disease: Novel insight from left atrial feature tracking , 2020, Clinical cardiology.

[6]  C. Berry,et al.  Treatment of coronary microvascular dysfunction. , 2020, Cardiovascular research.

[7]  S. Reis,et al.  Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women. , 2019, Journal of the American College of Cardiology.

[8]  L. Cripe,et al.  Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy , 2018, Neuromuscular Disorders.

[9]  A. Luttun,et al.  Molecular signature of progenitor cells isolated from young and adult human hearts , 2018, Scientific Reports.

[10]  E. Marbán.  A mechanistic roadmap for the clinical application of cardiac cell therapies , 2018, Nature Biomedical Engineering.

[11]  P. Libby,et al.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.

[12]  W. Paulus,et al.  Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction. , 2016, JACC. Heart failure.